Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
N/A
-1,150,000 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
N/A
-1,101,255 Reduced 48.92%
1,150,000 $5.65 Million
Q2 2021

Aug 16, 2021

BUY
N/A
2,251,255 New
2,251,255 $11.9 Million
Q2 2019

Aug 14, 2019

SELL
N/A
-1,050,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
N/A
-1,516,386 Reduced 59.09%
1,050,000 $7.47 Million
Q4 2018

Feb 14, 2019

BUY
N/A
122,686 Added 5.02%
2,566,386 $21.9 Million
Q3 2018

Nov 14, 2018

BUY
N/A
171,585 Added 7.55%
2,443,700 $48.9 Million
Q2 2018

Aug 14, 2018

BUY
N/A
235,515 Added 11.56%
2,272,115 $58.7 Million
Q1 2018

May 15, 2018

SELL
N/A
-72,855 Reduced 3.45%
2,036,600 $48.7 Million
Q4 2017

Feb 14, 2018

BUY
N/A
1,259,290 Added 148.12%
2,109,455 $71.5 Million
Q3 2017

Nov 14, 2017

BUY
N/A
850,165
850,165 $18 Million

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.